Experimental DMD infusion: first safety check in just 3 boys
NCT ID NCT06114056
First seen Mar 25, 2026 · Last updated May 23, 2026 · Updated 6 times
Summary
This early-stage study tests a single intravenous dose of JWK007 in 3 boys aged 5-10 with Duchenne muscular dystrophy (DMD). The main goal is to check safety and side effects, while also looking at whether it helps muscle function. It is a very small, first-in-human trial, so it focuses on safety rather than proving the treatment works.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DUCHENNE MUSCULAR DYSTROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.